Collegium Pharmaceutical, Inc. (COLL) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 8 Buy, 3 Hold, 1 Sell.
The consensus price target is $58.00 (low: $56.00, high: $60.00), representing an upside of 62.7% from the current price $35.64.
Analysts estimate Earnings Per Share (EPS) of $6.18 and revenue of $0.63B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.14 vs est $6.18 (missed -65.4%). 2025: actual $1.98 vs est $7.47 (missed -73.5%). Analyst accuracy: 0%.
COLL Stock — 12-Month Price Forecast
$58.00
▲ +62.74% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Collegium Pharmaceutical, Inc., the average price target is $58.00, with a high forecast of $60.00, and a low forecast of $56.00.
The average price target represents a +62.74% change from the last price of $35.64.
Highest Price Target
$60.00
Average Price Target
$58.00
Lowest Price Target
$56.00
COLL Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Collegium Pharmaceutical, Inc. in the past 3 months
EPS Estimates — COLL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $2.14
vs Est $6.18
▼ 188.8% off
2025
Actual $1.98
vs Est $7.47
▼ 277.3% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — COLL
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.631B
vs Est $0.629B
▲ 0.3% off
2025
Actual $0.781B
vs Est $0.781B
▼ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
